Recludix Pharma, a leader in discovery of inhibitors of challenging targets for inflammatory disease, today announced that ...

The combination of ACT001 and radiotherapy elicited responses and was considered well tolerated in a phase 2 trial of pediatric patients with newly diagnosed DIPG.

Bio-Path Holdings Inc (BPTH) reports progress in clinical trials and improved financial performance despite cash reserve ...

Fintel reports that on November 18, 2024, Stephens & Co. initiated coverage of Kymera Therapeutics (NasdaqGM:KYMR) with a ...

Analysts at Stephens initiated coverage on shares of Kymera Therapeutics (NASDAQ:KYMR – Get Free Report) in a report issued ...

Researchers have unlocked a key in a person's immune response that could halt the spread of cancer the body cannot see.

Scientists at the Garvan Institute of Medical Research have uncovered a connection between certain genetic variations and the ...

Lead researcher, Dr Aleks Guanizo explained: "We identified a cascade in which the protein STAT3 is essential to maintain the ...

In 2023, we published another article about CRSP in Cell Biology Education – A Journal of Life Science Education. That article assesses the impact of shifting research modalities and their impacts on ...